Literature DB >> 19892875

Adenovirus vectors targeting distinct cell types in the retina.

J Harry Sweigard1, Siobhan M Cashman, Rajendra Kumar-Singh.   

Abstract

Purpose. Gene therapy for a number of retinal diseases necessitates efficient transduction of photoreceptor cells. Whereas adenovirus (Ad) serotype 5 (Ad5) does not transduce photoreceptors efficiently, previous studies have demonstrated improved photoreceptor transduction by Ad5 pseudotyped with Ad35 (Ad5/F35) or Ad37 (Ad5/F37) fiber or by the deletion of the RGD domain in the Ad5 penton base (Ad5DeltaRGD). However, each of these constructs contained a different transgene cassette, preventing the evaluation of the relative performance of these vectors, an important consideration before the use of these vectors in the clinic. The aim of this study was to evaluate these vectors in the retina and to attempt photoreceptor-specific transgene expression. Methods. Three Ad5-based vectors containing the same expression cassette were generated and injected into the subretinal space of adult mice. Eyes were analyzed for green fluorescence protein expression in flat-mounts, cross-sections, quantitative RT-PCR, and a modified stereological technique. A 257-bp fragment derived from the mouse opsin promoter was analyzed in the context of photoreceptor-specific transgene expression. Results. Each virus tested efficiently transduced the retinal pigment epithelium. The authors found no evidence that Ad5/F35 or Ad5/F37 transduced photoreceptors. Instead, they found that Ad5/F37 transduced Müller cells. Robust photoreceptor transduction by Ad5DeltaRGD was detected. Photoreceptor-specific transgene expression from the 257-bp mouse opsin promoter in the context of Ad5DeltaRGD vectors was found. Conclusions. Adenovirus vectors may be designed with tropism to distinct cell populations. Robust photoreceptor-specific transgene expression can be achieved in the context of Ad5DeltaRGD vectors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892875      PMCID: PMC2868406          DOI: 10.1167/iovs.09-4367

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  31 in total

1.  In vivo transduction of photoreceptors or ciliary body by intravitreal injection of pseudotyped adenoviral vectors.

Authors:  Dan J Von Seggern; Edith Aguilar; Karen Kinder; Shonna Kaye Fleck; J C Gonzalez Armas; Susan C Stevenson; Peter Ghazal; Glen R Nemerow; Martin Friedlander
Journal:  Mol Ther       Date:  2003-01       Impact factor: 11.454

2.  Adenovirus type 37 uses sialic acid as a cellular receptor.

Authors:  N Arnberg; K Edlund; A H Kidd; G Wadell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector.

Authors:  I H Kim; A Józkowicz; P A Piedra; K Oka; L Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

4.  Tractional force generation by human müller cells: growth factor responsiveness and integrin receptor involvement.

Authors:  Clyde Guidry; Kelley M Bradley; Jeffery L King
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-03       Impact factor: 4.799

5.  Disruption of mouse CD46 causes an accelerated spontaneous acrosome reaction in sperm.

Authors:  Naokazu Inoue; Masahito Ikawa; Tomoko Nakanishi; Misako Matsumoto; Midori Nomura; Tsukasa Seya; Masaru Okabe
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

6.  Focal adhesion kinase signaling promotes phagocytosis of integrin-bound photoreceptors.

Authors:  Silvia C Finnemann
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

7.  CD46 is a cellular receptor for group B adenoviruses.

Authors:  Anuj Gaggar; Dmitry M Shayakhmetov; André Lieber
Journal:  Nat Med       Date:  2003-10-19       Impact factor: 53.440

8.  Adenovirus type 5 pseudotyped with adenovirus type 37 fiber uses sialic acid as a cellular receptor.

Authors:  Siobhan M Cashman; David J Morris; Rajendra Kumar-Singh
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

9.  Expression and modulation of RPE cell membrane complement regulatory proteins.

Authors:  Ping Yang; Jillian Tyrrell; Ian Han; Glenn J Jaffe
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-24       Impact factor: 4.799

10.  Efficient gene transfer into retinal cells using adenoviral vectors: dependence on receptor expression.

Authors:  Joshua N Mallam; Mary Y Hurwitz; Timothy Mahoney; Patricia Chévez-Barrios; Richard L Hurwitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-06       Impact factor: 4.799

View more
  15 in total

Review 1.  Let There Be Light: Gene and Cell Therapy for Blindness.

Authors:  Deniz Dalkara; Olivier Goureau; Katia Marazova; José-Alain Sahel
Journal:  Hum Gene Ther       Date:  2016-02       Impact factor: 5.695

Review 2.  Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.

Authors:  Pasqualina Colella; Alberto Auricchio
Journal:  Hum Gene Ther       Date:  2012-08       Impact factor: 5.695

3.  Primate neural retina upregulates IL-6 and IL-10 in response to a herpes simplex vector suggesting the presence of a pro-/anti-inflammatory axis.

Authors:  Monica M Sauter; Curtis R Brandt
Journal:  Exp Eye Res       Date:  2016-05-08       Impact factor: 3.467

4.  Suppression of laser-induced choroidal neovascularization by intravitreal injection of tristetraprolin.

Authors:  Yong Wun Cho; Yong Seop Han; In Young Chung; Seong Jae Kim; Seong Wook Seo; Ji Myong Yoo; Jong Moon Park
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

5.  Adenovirus-mediated delivery of CD46 attenuates the alternative complement pathway on RPE: implications for age-related macular degeneration.

Authors:  J H Sweigard; S M Cashman; R Kumar-Singh
Journal:  Gene Ther       Date:  2011-02-10       Impact factor: 5.250

Review 6.  Viral vectors and delivery strategies for CNS gene therapy.

Authors:  Steven J Gray; Kenton T Woodard; R Jude Samulski
Journal:  Ther Deliv       Date:  2010-10

7.  Retinal Gene Therapy: Current Progress and Future Prospects.

Authors:  Cristy A Ku; Mark E Pennesi
Journal:  Expert Rev Ophthalmol       Date:  2015-04-10

8.  Pigment epithelium-derived factor released by Müller glial cells exerts neuroprotective effects on retinal ganglion cells.

Authors:  Jan Darius Unterlauft; Wolfram Eichler; Konstantin Kuhne; Xiu Mei Yang; Yousef Yafai; Peter Wiedemann; Andreas Reichenbach; Thomas Claudepierre
Journal:  Neurochem Res       Date:  2012-03-13       Impact factor: 3.996

Review 9.  Vector platforms for gene therapy of inherited retinopathies.

Authors:  Ivana Trapani; Agostina Puppo; Alberto Auricchio
Journal:  Prog Retin Eye Res       Date:  2014-08-12       Impact factor: 21.198

Review 10.  Gene therapy in animal models of autosomal dominant retinitis pigmentosa.

Authors:  Brian Rossmiller; Haoyu Mao; Alfred S Lewin
Journal:  Mol Vis       Date:  2012-10-06       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.